Cargando…
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer
Cisplatin resistance remains one of the major obstacles when treating epithelial ovarian cancer. Because oxaliplatin and nedaplatin are effective against cisplatin-resistant ovarian cancer in clinical trials and signal transducer and activator of transcription 3 (STAT3) is associated with cisplatin...
Autores principales: | Sheng, W.J., Jiang, H., Wu, D.L., Zheng, J.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854422/ https://www.ncbi.nlm.nih.gov/pubmed/23969971 http://dx.doi.org/10.1590/1414-431X20133003 |
Ejemplares similares
-
Liver cancer stem cells are selectively enriched by
low-dose cisplatin
por: Zhang, H., et al.
Publicado: (2014) -
Global microRNA profiles and signaling pathways in the
development of cardiac hypertrophy
por: Feng, H.J., et al.
Publicado: (2014) -
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes
by attenuating IRS-1/PI3K/Akt pathway inhibition
por: Li, H.B., et al.
Publicado: (2015) -
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the
ERK pathway
por: Bai, R.X., et al.
Publicado: (2016) -
CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant
animal model in vivo
por: Wang, X.M., et al.
Publicado: (2014)